Cannella B - Search Results

1

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease.

Sommer N, Martin R, McFarland HF, Quigley L, Cannella B, Raine CS, Scott DE, Löschmann PA, Racke MK. Sommer N, et al. Among authors: cannella b. J Neuroimmunol. 1997 Oct;79(1):54-61. doi: 10.1016/s0165-5728(97)00111-2. J Neuroimmunol. 1997. PMID: 9357447

2

Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis.

Racke MK, Cannella B, Albert P, Sporn M, Raine CS, McFarlin DE. Racke MK, et al. Among authors: cannella b. Int Immunol. 1992 May;4(5):615-20. doi: 10.1093/intimm/4.5.615. Int Immunol. 1992. PMID: 1378298

3

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Racke MK, et al. Among authors: cannella b. J Immunol. 1991 May 1;146(9):3012-7. J Immunol. 1991. PMID: 1707929

4

Relapsing autoimmune demyelination: a role for vascular addressins.

Cannella B, Cross AH, Raine CS. Cannella B, et al. J Neuroimmunol. 1991 Dec;35(1-3):295-300. doi: 10.1016/0165-5728(91)90183-8. J Neuroimmunol. 1991. PMID: 1955571

5

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.

Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Röcken M. Racke MK, et al. Among authors: cannella b. J Exp Med. 1994 Nov 1;180(5):1961-6. doi: 10.1084/jem.180.5.1961. J Exp Med. 1994. PMID: 7525845 Free PMC article.

6

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.

Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE. Racke MK, et al. Among authors: cannella b. J Immunol. 1995 Jan 1;154(1):450-8. J Immunol. 1995. PMID: 7527821

7

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2.

Racke MK, Sriram S, Carlino J, Cannella B, Raine CS, McFarlin DE. Racke MK, et al. Among authors: cannella b. J Neuroimmunol. 1993 Jul;46(1-2):175-83. doi: 10.1016/0165-5728(93)90247-v. J Neuroimmunol. 1993. PMID: 7689586

8

Intravenous antigen administration as a therapy for autoimmune demyelinating disease.

Racke MK, Critchfield JM, Quigley L, Cannella B, Raine CS, McFarland HF, Lenardo MJ. Racke MK, et al. Among authors: cannella b. Ann Neurol. 1996 Jan;39(1):46-56. doi: 10.1002/ana.410390108. Ann Neurol. 1996. PMID: 8572666

9

Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination.

Cross AH, Cannella B, Brosnan CF, Raine CS. Cross AH, et al. Among authors: cannella b. J Neuroimmunol. 1991 Sep;33(3):237-44. doi: 10.1016/0165-5728(91)90111-j. J Neuroimmunol. 1991. PMID: 1714920 Review. No abstract available.

10

Cytokines up-regulate Ia expression in organotypic cultures of central nervous system tissue.

Cannella B, Raine CS. Cannella B, et al. J Neuroimmunol. 1989 Oct;24(3):239-48. doi: 10.1016/0165-5728(89)90122-7. J Neuroimmunol. 1989. PMID: 2808691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters